anmelden
SMI
13.240,70
PKT
+20,53
PKT
+0,16
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.01.17 | UBS Neutral | Credit Suisse Group | |
| 27.01.17 | UBS Outperform | RBC Capital Markets | |
| 27.01.17 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 27.01.17 | UBS overweight | Barclays Capital | |
| 27.01.17 | UBS buy | S&P Capital IQ | |
| 27.01.17 | UBS buy | Baader Bank | |
| 27.01.17 | UBS Hold | Commerzbank AG | |
| 26.01.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 26.01.17 | Novartis Underweight | Morgan Stanley | |
| 26.01.17 | Novartis Hold | Deutsche Bank AG | |
| 26.01.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 26.01.17 | UBS buy | Goldman Sachs Group Inc. | |
| 25.01.17 | UBS Buy | UBS AG | |
| 25.01.17 | Novartis Hold | S&P Capital IQ | |
| 25.01.17 | UBS Hold | Deutsche Bank AG | |
| 25.01.17 | UBS Hold | Deutsche Bank AG | |
| 25.01.17 | Nestlé buy | UBS AG | |
| 25.01.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 25.01.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 25.01.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 25.01.17 | Zurich Insurance Outperform | BNP PARIBAS | |
| 25.01.17 | Novartis Outperform | Bernstein Research | |
| 25.01.17 | Novartis buy | Baader Bank | |
| 24.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 24.01.17 | UBS buy | Baader Bank | |
| 24.01.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 24.01.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 24.01.17 | UBS buy | HSBC | |
| 23.01.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 23.01.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 23.01.17 | Roche overweight | JP Morgan Chase & Co. | |
| 23.01.17 | UBS Equal-Weight | Morgan Stanley | |
| 23.01.17 | UBS overweight | Morgan Stanley | |
| 23.01.17 | Nestlé overweight | Barclays Capital | |
| 20.01.17 | UBS Hold | Deutsche Bank AG | |
| 20.01.17 | Swiss Re Hold | Deutsche Bank AG | |
| 19.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.01.17 | Holcim buy | Deutsche Bank AG | |
| 18.01.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 18.01.17 | UBS buy | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.